Inventor · disambiguated record
Jun Qi
Also filed as: QI JUN
37 granted patents·18 pending applications·211 citations·filing 2011–2025
97Inventor score
Files withDANA FARBER CANCER INST INC49BRADNER JAMES ELLIOTT2CHILDRENS MEDICAL CT CORP2WHITEHEAD BIOMEDICAL INST1ZHANG XIAOFENG1
Top patents by PatentIndex Score
55 records- 0198US9714946B2Bromodomain binding reagents and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted Jul 25, 2017·41 cites·13 claims
- 0298US9320741B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2014·Granted Apr 26, 2016·23 cites·10 claims
- 0397US10407441B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2018·Granted Sep 10, 2019·10 cites·18 claims
- 0496US8981083B2Compositions and methods for treating neoplasia, inflammatory disease and other disordersBRADNER JAMES ELLIOTT·Filed 2011·Granted Mar 17, 2015·26 cites·6 claims
- 0593US11845728B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2021·Granted Dec 19, 2023·2 cites·24 claims
- 0693US9789120B2Male contraceptive compositions and methods of useDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 17, 2017·16 cites·26 claims
- 0792US9301962B2Male contraceptive compositions and methods of useBRADNER JAMES ELLIOTT·Filed 2011·Granted Apr 5, 2016·23 cites·22 claims
- 0891US10934256B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2019·Granted Mar 2, 2021·4 cites·18 claims
- 0991US9695172B2Diazepane derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·13 cites·74 claims
- 1090US10464897B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 5, 2019·4 cites·17 claims
- 1190US10150756B2Diaminopyrimidine benzenesulfone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Dec 11, 2018·9 cites·19 claims
- 1289US11999729B2Small molecule inhibition of transcription factor SALL4 and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Granted Jun 4, 2024·1 cites·22 claims
- 1389US10980808B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Apr 20, 2021·4 cites·9 claims
- 1488US9975896B2Inhibitors of transcription factors and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted May 22, 2018·17 cites·33 claims
- 1587US10881668B2Acetamide thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 5, 2021·4 cites·20 claims
- 1686US11944625B2Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathiesCHILDRENS MEDICAL CT CORP·Filed 2021·Granted Apr 2, 2024·1 cites·17 claims
- 1784US12441685B2Compounds and methods for treating cancerDANA FARBER CANCER INST INC·Filed 2023·Granted Oct 14, 2025·0 cites·20 claims
- 1884US10793571B2Uses of diazepane derivativesDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 6, 2020·2 cites·20 claims
- 1980US11306105B2Cyano thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Apr 19, 2022·3 cites·28 claims
- 2079US11731967B2Inhibitors of TRIM33 and methods of useDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 22, 2023·3 cites·5 claims
- 2178US10730860B2Diaminopyrimidine benzenesulfone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Aug 4, 2020·1 cites·22 claims
- 2276US11530209B2Small molecule inhibition of transcription factor SALL4 and uses thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Dec 20, 2022·1 cites·22 claims
- 2375US11634450B2DOT1L degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Apr 25, 2023·2 cites·28 claims
- 2474US10913752B2Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 9, 2021·1 cites·30 claims
- 2571US2020148702A1Compositions and methods for treating neoplasia, inflammatory disease and other disordersDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 2670US2025034126A1Chromobox protein inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2024·Application pending·0 cites
- 2765US2024067641A1Inhibitors of trim33 and methods of useDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 2864US2025066326A1Bcl6 degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 2964US2025333402A1Acetylation writer inhibitor development and uses thereofDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
- 3063US2024409574A1Small molecules for dot1l degradation and uses thereofDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 3162US11406645B2Acetamide thienotriazolodiazepines and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Aug 9, 2022·0 cites·21 claims
- 3261US2022119416A9Bivalent bromodomain inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 3361US2017029437A1Compositions and Methods for Treating Neoplasia, Inflammatory Disease and Other DisordersDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
- 3458US12331069B2DOT1L degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Jun 17, 2025·0 cites·17 claims
- 3556US12428412B2Acetylation writer inhibitor development and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Sep 30, 2025·0 cites·30 claims
- 3655US11236082B2EZH2 inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Feb 1, 2022·0 cites·24 claims
- 3755US2025163024A1Chemical targeting swi/snf related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (smarca4) and use in diffuse intrinsic pontine glioma (dipg)DANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 3855US2024335438A1Targeting dot1l and smarca4/2 for the treatment of mllr leukemiaDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 3954US12129248B2Chromobox protein inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 29, 2024·0 cites·10 claims
- 4052US12479852B2Compounds, compositions, and methods for protein degradationDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 25, 2025·0 cites·21 claims
- 4151US2024156800A1Ep300 degrader and uses thereof in neuroblastomaDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 4251US2023149551A1Arginine methyltransferase 5 (prmt5) degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 4349US9535067B2DOT1L probesDANA FARBER CANCER INST INC·Filed 2014·Granted Jan 3, 2017·0 cites·21 claims
- 4449US9458165B2DOT1L inhibitorsDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 4, 2016·0 cites·15 claims
- 4549US2022348563A1Kdm inhibitors and uses thereofZHANG XIAOFENG·Filed 2020·Application pending·0 cites
- 4649US2022242872A1E3 ligase binders and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 4749US2022227700A1Hdac3 catalytic inhibitor development and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 4846US12496348B2Small molecule target bromo/acetyl proteins and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Dec 16, 2025·0 cites·25 claims
- 4945US11702402B2Small molecules that block proteasome-associated ubiquitin receptor RPN13 function and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Jul 18, 2023·0 cites·20 claims
- 5043US11802132B2Small molecules for inducing selective protein degradation and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Oct 31, 2023·0 cites·14 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jun Qi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →